NeoGenomics, Inc. (NEO) Profit Margins
Over the twelve months to 2026-06-30, NeoGenomics, Inc. (NEO) had gross margin 43.9%, operating margin -8.9%, net margin -6.8%, free cash flow margin -1.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NEONeoGenomics, Inc.Follow NEO — free
—
Price chart with a free account
- Market cap
- 2.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 46.0% | 48.1% | 41.8% | 38.6% | 36.9% | 41.3% | 43.9% | 43.2% | 43.9% | |
| Operating margin | 3.6% | 3.2% | -3.1% | -24.5% | -30.9% | -18.2% | -13.9% | -15.9% | -8.9% | |
| Net margin | 1.0% | 2.0% | 0.9% | -1.7% | -28.3% | -14.9% | -11.9% | -14.9% | -6.8% | |
| FCF margin | 11.0% | 0.8% | -6.2% | -18.8% | -19.0% | -5.2% | -5.2% | -3.0% | -1.0% |
USD billions · SEC XBRL
NeoGenomics, Inc. — questions
- What is NeoGenomics, Inc.'s gross margin?
- 43.9% over the twelve months to 2026-06-30.
- What is NeoGenomics, Inc.'s operating margin?
- -8.9% over the twelve months to 2026-06-30.
- What is NeoGenomics, Inc.'s net profit margin?
- -6.8% over the twelve months to 2026-06-30.
Every figure on this page comes from NeoGenomics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.